Quantinno Capital Management LP

Position in TXG — 10x Genomics, Inc.

CIK 1759654 NEW YORK, NY

Position in TXG

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$209,708,221

+$94,816,535 QoQ

Shares Held

5,469,698

+1.1% QoQ

Ownership

4.20%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Quantinno Capital Management LP holds $1,013,353,919 across 58 Medical Devices names. TXG ranks #1 (20.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TXG	10x Genomics, Inc. This page	5,469,698	$209,708,221
2	EW	Edwards Lifesciences Corp	1,252,407	$113,292,737
3	GMED	Globus Medical Inc	1,219,098	$96,320,932
4	ABT	Abbott Laboratories	788,559	$71,553,843
5	ZBH	Zimmer Biomet Holdings, Inc.	722,139	$62,168,946
6	SYK	Stryker Corp	173,466	$54,614,035
7	MDT	Medtronic plc	631,667	$49,415,309
8	PODD	Insulet Corp	316,922	$48,251,374

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$209,708,221	5,469,698	+1.1%	Shares	Sole	2026-08-13
2026-03-31	$114,891,686	5,411,761	+16.0%	Shares	Sole	2026-05-15
2025-12-31	$76,122,080	4,667,203	+33.6%	Shares	Sole	2026-02-17
2025-09-30	$40,826,845	3,492,459	+56.4%	Shares	Sole	2025-11-14
2025-06-30	$25,864,231	2,233,526	+207.2%	Shares	Sole	2025-08-14
2025-03-31	$6,346,675	726,996	+385.2%	Shares	Sole	2025-05-12
2024-12-31	$2,151,601	149,833	-36.2%	Shares	Sole	2025-02-14
2024-09-30	$5,306,887	235,026	+380.5%	Shares	Sole	2024-11-14
2024-06-30	$951,396	48,915	+112.1%	Shares	Sole	2024-08-14
2024-03-31	$865,554	23,063	-46.8%	Shares	Sole	2024-05-14
2023-12-31	$2,423,907	43,315	+360.2%	Shares	Sole	2024-02-14
2023-09-30	$388,286	9,413	-68.0%	Shares	Sole	2023-11-14
2023-06-30	$1,642,924	29,422	—	Shares	Sole	2023-08-04
No filing history on record for this holder in this stock.